Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.27) by 19.85 percent. This is a 10.34 percent decrease over losses of $(0.29) per share from the same period last year.
Edesa Biotech (NASDAQ:EDSA) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.27) by 19.85 percent. This is a 10.34 percent decrease over losses of $(0.29) per share from the same period last year.
Comments